[Rheumatology 2010].
Hermann
W
W
Lehrstuhl für Innere Medizin mit Schwerpunkt Rheumatologie der Justus-Liebig Universität Giessen, Abteilung für Rheumatologie und klinische Immunologie, Kerckhoff-Klinik Bad Nauheim, Bad Nauheim.
Müller-Ladner
U
U
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000209:etiology / Q000628:therapy*; D015519:Bone Density; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000209:etiology / Q000628:therapy*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010024:Osteoporosis / Q000209:etiology / Q000628:therapy; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D047428:Protein Kinase Inhibitors; C511911:belimumab; D009173:Mycophenolic Acid